Clinical outcome in patients with small intestinal non-Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 10, 2009, Pages 1618-1624

  Kako, Shinichi ^a   Oshima, Kumi ^a   Sato, Miki ^a   Terasako, Kiriko ^a   Okuda, Shinya ^a   Nakasone, Hideki ^a   Yamazaki, Rie ^a   Tanaka, Yukie ^a   Tanihara, Aki ^a   Kawamura, Yutaka ^a   Kiyosaki, Hirokazu ^a   Higuchi, Takakazu ^a   Nishida, Junji ^a   Konishi, Fumio ^a   Kanda, Yoshinobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Abdominal symptoms; Perforation; Small intestinal lymphoma; Surgical procedure

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; INTESTINE INJURY; INTESTINE LYMPHOMA; INTESTINE PERFORATION; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MEDICAL RECORD REVIEW; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SYMPTOM; T CELL LYMPHOMA; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; ILEAL NEOPLASMS; INTESTINAL OBSTRUCTION; INTESTINAL PERFORATION; JAPAN; JEJUNAL NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70350784070     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903147629     Document Type: Article

References (31)

1. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-737.
2. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: A clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003;97:2462-2473.
3. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007;136:521-538.
4. Schmidt WP, Schmitz N, Sonnen R. Conservative management of gastric lymphoma: The treatment option of choice. Leuk Lymphoma 2004;45:1847-1852.
5. Bertoni F, Zucca E. State-of-the-art therapeutics: Marginalzone lymphoma. J Clin Oncol 2005;23:6415-6420.
6. Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993;17:429-442.
7. Nakamura S, Matsumoto T, Takeshita M, et al. A clinicopathologic study of primary small intestine lymphoma: Prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 2000;88:286-294.
8. Li B, Shi YK, He XH, et al. Primary non-Hodgkin lymphomas in the small and large intestine: Clinicopathological characteristics and management of 40 patients. Int J Hematol 2008;87:375-381.
9. Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 66 patients. Ann Oncol 2001;12:53-58.
10. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin's lymphoma: A multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 2003;21:2740-2746.
11. Kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, Kikuchi M. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 2003;43:135-143.
12. Yokota T, Meguro K, Yamada Y, Kikuchi S, Yamauchi H, Hatori M. Diffuse peritonitis caused by perforation of ileal lymphoma: Two case reports and clinicopathological features of 81 cases in Japan. Leuk Lymphoma 2006;47: 1157-1159.
13. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980;46:215-222.
14. Amer MH, El-Akkad S. Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterology 1994;106:846-858.
15. Jaffe E, Harris NL, Stein H, Rardiman JW. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
16. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 1978;42:693-707. (Pubitemid 8405865)
17. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
18. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1861.
19. Rosenberg SA, Boiron M, DeVita VT Jr., et al. Report of the committee on Hodgkin's disease staging procedures. Cancer Res 1971;31:1862-1863.
20. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
21. A predictive model for aggressive non-Hodgkin's lymphoma. The International non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993;329:987-994.
22. Aozasa K, Tsujimoto M, Inoue A, et al. Primary gastrointestinal lymphoma. A clinicopathologic study of 102 patients. Oncology 1985;42:97-103.
23. Azab MB, Henry-Amar M, Rougier P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer 1989;64:1208-1217.
24. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 1992;102:1628-1638.
25. d'Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: A population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 1994;12:1673-1684.
26. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803.
27. Sunada K, Yamamoto H. Double-balloon endoscopy: Past, present, and future. J Gastroenterol 2009;44:1-12.
28. Ullerich H, Franzius C, Domagk D, et al. 18F-fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: The only sensitive method of imaging. Am J Gastroenterol 2001;96:2497-2499.
29. Sam JW, Levine MS, Farner MC, Schuster SJ, Alavi A. Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography. Clin Nucl Med 2002;27:330-333.
30. Hoffmann M, Vogelsang H, Kletter K, Zettinig G, Chott A, Raderer M. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 2003;52: 347-351. (Pubitemid 36250052)
31. Gobbi PG, Ghirardelli ML, Cavalli C, et al. The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica 2000;85: 372-380.